PDL BioPharma Inc. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
264,530.00
322,244.00
332,795.00
63,659.00
110,701.00
68,859
Depreciation, Depletion & Amortization
5,637.00
-
-
12,028.00
24,689.00
15,831
Other Funds
22.00
-
-
14,400.00
87,007.00
47,780
Funds from Operations
282,923.00
283,646.00
292,274.00
116,397.00
20,446.00
8,598
Changes in Working Capital
12,033.00
8,635.00
9,191.00
14,679.00
20,178.00
22,023
Net Operating Cash Flow
270,890.00
292,281.00
301,465.00
101,718.00
40,624.00
13,425
Capital Expenditures
241,316.00
81,149.00
115,009.00
59,525.00
1,297.00
Sale of Fixed Assets & Businesses
-
-
-
250.00
-
Purchase/Sale of Investments
33,905.00
1,780.00
1,947.00
93,272.00
91,743.00
Net Investing Cash Flow
297,985.00
138,109.00
79,648.00
144,260.00
456,717.00
Cash Dividends Paid - Total
84,006.00
96,557.00
98,307.00
16,583.00
222.00
Issuance/Reduction of Debt, Net
74,169.00
158,984.00
24,393.00
121,796.00
-
Net Financing Cash Flow
9,815.00
42,903.00
294,311.00
29,187.00
117,229.00
Net Change in Cash
36,910.00
197,075.00
72,494.00
71,729.00
380,112.00
Free Cash Flow
270,888.00
292,232.00
301,456.00
101,693.00
39,327.00
Deferred Taxes & Investment Tax Credit
999.00
19,842.00
17,251.00
10,676.00
39,172.00
13,846
Net Assets from Acquisitions
-
-
-
109,938.00
2,170.00
Other Sources
58,134.00
171,260.00
68,649.00
127,235.00
368,441.00
Change in Capital Stock
-
19,524.00
220,397.00
120,000.00
30,000.00
Other Uses
148,708.00
230,000.00
35,235.00
9,010.00
-
About PDL BioPharma
View Profile
